Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly’s Zepbound, but they have to stop Wednesday. That’s left many patients wondering what to do next.
(Image credit: Guido Mieth)
Patients scramble as cheaper obesity drug alternatives disappear from NPR Sydney Lupkin
